fate stock price target

Stock Price Forecast The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 8200 with a high estimate of 13500 and a low estimate of 2800. According to the issued ratings of 11 analysts in the last year the consensus rating for Fate Therapeutics stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for FATE.

Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S

FATE updated stock price target summary.

. Amount of Analyst Coverage Fate. Find the latest Fate Therapeutics Inc. Stock Price Target FATE.

On average analysts give the stock a Strong Buy rating. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Extra money in your bank account.

Fate Therapeutics Stock Forecast 06-17-2022. Of note is the ratio of Fate Therapeutics Incs sales and general administrative expense to its total operating expenses. Find a Dedicated Financial Advisor Now.

FATE stock price quote with breaking news financials statistics charts and more. Given the current short-term. According to 7 Wall Street analyst s that have issued a 1 year FATE price target the average FATE price target is 7643 with the highest FATE stock price forecast at 11500 and the lowest.

Based on analysts offering 12 month price targets for FATE in the last 3 months. The 3 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of 860 with a high forecast of 1220 and a low forecast of 620. Ad Our Strong Buys Double the SP.

49 rows FATE Stock Trend. FATE analyst stock forecast price target and recommendation trends with in-depth. Visit The Official Edward Jones Site.

FATE were skyrocketing 473 higher as of 1143 am. Ad These 5 companies are set for historic price action. Get a real-time Fate Therapeutics Inc.

According to MarketBeat Fate Therapeutics has a consensus rating of Moderate Buy and an average target price of 8036. NASDAQFATE - Get Rating insider Mark Plavsic sold 3719 shares of the companys stock in a transaction that occurred on Tuesday July 5th. FATE stock forecast and price target.

Fate Therapeutics Inc. According to analysts consensus price target of 8036 Fate Therapeutics has a forecasted upside of 2197 from its current price of 2514. New Look At Your Financial Strategy.

One of the most common ways Fate Therapeutics analysts use to provide buy-or-sell. The average price target is 103866 which means analysts. What happenedShares of Fate Therapeutics NASDAQ.

1y Target Est 8150 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate. Positive dynamics for Fate Therapeutics shares will prevail with possible. Learn more on FATEs analyst rating.

Fate Therapeutics stock price target raised to 79 from 58 at Stifel Nicolaus Dec. When you sign up youll reveal the names and ticker symbols of these 5 companies. FATEs rank also includes a long-term technical score of 99.

That rank is mainly influenced by a short-term technical score of 100. 7 2020 at 750 am. Heres where we think you should invest.

The average twelve-month price prediction for Fate Therapeutics is 8036 with a high price target of 11600 and a low price target of 2800. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Forecast target price for 06-17-2022.

Now is the time to move. A high-level overview of Fate Therapeutics Inc. Based On Fundamental Analysis.

Fate Therapeutics Inc FATE Stock Analysis Based on the Fate Therapeutics Inc stock forecasts from 8 analysts the average analyst target price for Fate Therapeutics Inc is USD 7300 over. Analyst ratings historical stock prices earnings estimates actuals. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

ET by Tomi Kilgore Fate Therapeutics stock price target raised to 88 from 55 at Wedbush. Merely 827 of US stocks have a lower. Based on 9 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months.

Analyst Price Target on FATE. The fundamental score for FATE is 1. The average price target is 7043 with a high forecast.

The current projected Fate Therapeutics target price consensus is 1072 with 15 analyst opinions. The stock has a market capitalization of 259. Ad Do Your Investments Align with Your Goals.

Ad Diversify your portfolio with guidance from investment professionals. The huge jump came after the biotech. Get a real-time Fate Therapeutics Inc.

Wall Street is positive on Fate Therapeutics Inc FATE.

Cathie Wood Pours Money Into 3 Strong Buy Innovation Stocks